Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLONAZEPAM vs CLOPIDOGREL BISULFATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLONAZEPAM vs CLOPIDOGREL BISULFATE: Safety Overview

Metric CLONAZEPAM CLOPIDOGREL BISULFATE
Total FAERS Reports 39,463 46,012
Deaths Reported 8,488 5,327
Death Rate 21.5% 11.6%
Hospitalizations 12,506 24,774
Average Patient Age 46.0 yrs 70.0 yrs
% Female Patients 58.3% 41.2%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 11, 2014
Manufacturer Advagen Pharma Ltd Major Pharmaceuticals
Route ORAL ORAL
Marketing Status Prescription Prescription